2021
DOI: 10.1016/j.recesp.2020.06.025
|View full text |Cite
|
Sign up to set email alerts
|

Carga de comorbilidad y beneficio de la revascularización en ancianos con síndrome coronario agudo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 19 publications
(5 citation statements)
references
References 30 publications
0
5
0
Order By: Relevance
“…Mortality increased with a higher number of comorbidities [ 20 ]. Evidence suggests that the benefits or revascularization in older patients diminish with more comorbidity burden [ 21 ].…”
Section: Comorbiditiesmentioning
confidence: 99%
“…Mortality increased with a higher number of comorbidities [ 20 ]. Evidence suggests that the benefits or revascularization in older patients diminish with more comorbidity burden [ 21 ].…”
Section: Comorbiditiesmentioning
confidence: 99%
“…After propensity score matching, it showed that revascularization within the first 3 days of admission was associated to 32% reduction in all-cause mortality (hazard ratio: 0.68, 95% CI 0.55-0.84). This study had several limitations because it did not assess the effect of heart failure of index hospitalization on post-discharge prognosis, and heart failure incidence was not assessed taking all-cause mortality as a competing event [34,35].…”
Section: Non-stemi (Nstemi) Patients: Invasive Versus Conservative Treatment?mentioning
confidence: 99%
“…In an observational study, Chang et al found a lack of benefit of invasive strategy in the subgroup with higher comorbidity burden (i.e., Charlson Index ≥ 4). On the other hand, a retrospective study with >7200 patients aged ≥ 70 years from 11 Spanish ACS registries analyzed the impact of the six most common comorbidities (diabetes, peripheral artery disease, cerebrovascular disease, chronic pulmonary disease, renal failure, and anemia) on revascularization, finding that revascularization reduced 1-year mortality despite the presence of comorbidities [35]. The MOSCA trial randomized routine invasive vs. conservative strategy in comorbid older patients with non-STEMI.…”
Section: Geriatric Conditions: Frailty and Comorbiditymentioning
confidence: 99%
“…Registry investigators provided individual patient data to form a pooled patient database. Details of the cohorts are reported elsewhere [22]. Briefly, the study included patients aged 70 years or older with NSTEACS.…”
Section: Study Populationmentioning
confidence: 99%
“…Few studies have addressed to date the interaction between sex and DM in the prognosis of elderly patients with NSTEACS, and they have had contradictory results [20,21]. The present study comprised a pooled analysis of individual patient data that included elderly patients from 11 Spanish NSTEACS registries [22]. We aimed to study the prognostic influence of DM according to sex on 1-year mortality.…”
Section: Introductionmentioning
confidence: 99%